Share on StockTwits

Shares of MannKind (NASDAQ:MNKD) saw some unusual options trading activity on Tuesday. Investors purchased 10,263 call options on the stock, Analyst Ratings Network reports. This is an increase of 150% compared to the typical daily volume of 4,107 call options.

A number of research firms have recently commented on MNKD. Analysts at MLV & Co
reiterated a “buy” rating on shares of MannKind in a research note on Tuesday. They now have a $10.00 price target on the stock, down previously from $11.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of MannKind in a research note on Tuesday, April 22nd. They now have a $6.75 price target on the stock. Finally, analysts at Brinson Patrick initiated coverage on shares of MannKind in a research note on Tuesday, April 8th. They set an “outperform” rating and a $12.00 price target on the stock. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $6.71.

MannKind (NASDAQ:MNKD) traded up 3.95% on Tuesday, hitting $6.58. The stock had a trading volume of 8,089,206 shares. MannKind has a 52 week low of $3.80 and a 52 week high of $8.70. The stock has a 50-day moving average of $6.15 and a 200-day moving average of $5.60. The company’s market cap is $2.371 billion.

MannKind (NASDAQ:MNKD) last released its earnings data on Monday, May 12th. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.13) by $0.01. During the same quarter last year, the company posted ($0.15) earnings per share. Analysts expect that MannKind will post $-0.35 EPS for the current fiscal year.

MannKind Corporation (NASDAQ:MNKD) is a development-stage biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.